Soleno Therapeutics Inc (NASDAQ: SLNO) shares fell 0.16%, or $0.0015 per share, to close Monday at $0.94. After opening the day at $0.94, shares of Soleno fluctuated between $0.96 and $0.91. 565,940 shares traded hands a decrease from their 30 day average of 1,260,631. Monday’s activity brought Soleno’s market cap to $75,059,845.
Soleno is headquartered in Redwood City, California..
About Soleno Therapeutics Inc
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.